Resultados de la búsqueda

Farkouh ME and Fuster V. Diabetes and aspirin: beware of underpowered negative trials. Nat Clin Pract Cardiovasc Med (2009) 6:1

Garcia MJ, Fuster V. An ounce of prevention with a calcium score scan? JACC Cardiovasc Imaging (2009) 2:689-91

Sirol M, Moreno PR, Purushothaman KR, Vucic E, Amirbekian V, Weinmann HJ, Muntner P, Fuster V, Fayad ZA. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging (2009) 2:391-6

Martin de Francisco AL, Aguilera L, Fuster V. [Cardiovascular, renal and other chronic diseases. Early intervention is necessary in chronic kidney disease] Nefrologia (2009) 29:6-9

Fuster V, van der Zee S, Miller MA. Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy. J Cardiovasc Transl Res (2009) 2:398-406

Vedanthan R, Fuster V. Disease Prevention: The moving target of global cardiovascular health. Nat Rev Cardiol (2009) 6:327-8

Fischer A, Fuster V The Changing Epidemiology of Sudden Cardiac Death Card Electrophysiol Clin (2009) 1:1-11

Danielyan K, Ganguly K, Ding BS, Atochin D, Zaitsev S, Murciano JC, Huang PL, Kasner SE, Cines DB, Muzykantov VR. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation (2008) 118:1442-9

Ding BS, Hong N, Murciano JC, Ganguly K, Gottstein C, Christofidou-Solomidou M, Albelda SM, Fisher AB, Cines DB, Muzykantov VR. Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature. Blood (2008) 111:1999-2006

Palacios-Callender M, Hollis V, Frakich N, Mateo J, Moncada S. Cytochrome c oxidase maintains mitochondrial respiration during partial inhibition by nitric oxide. J Cell Sci (2007) 120:160-5